New 'Nimbus' COVID-19 Variant Spreads
Analysis based on 6 articles · First reported Jun 18, 2025 · Last updated Jun 25, 2025
The emergence of the new 'Nimbus' COVID-19 variant, while causing painful sore throats, is not expected to significantly impact markets as the World Health Organization has deemed the public health risk low and current vaccines effective. However, the controversial announcement by Robert F. Kennedy Jr. regarding vaccine recommendations could create minor uncertainty in the healthcare sector.
A new COVID-19 variant, NB.1.8.1. or 'Nimbus', has emerged, earning the nickname 'razor blade throat' due to the painful sore throats it may cause. Doctors in the United Kingdom and India have identified this symptom. The World Health Organization has designated Nimbus as a 'variant under monitoring' and assesses the global public health risk as low, with current vaccines expected to remain effective. The variant has been detected in the United States through airport screenings. Health Secretary Robert F. Kennedy Jr. recently announced that COVID-19 shots are no longer recommended for healthy children and pregnant women, a move that has been questioned by public health experts.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard